Molecule Holdings Inc. (MLCL.CN)
| Previous Close | 0.0150 |
| Open | 0.0100 |
| Bid | 0.0100 x N/A |
| Ask | 0.0150 x N/A |
| Day's Range | 0.0100 - 0.0100 |
| 52 Week Range | 0.0100 - 0.0850 |
| Volume | |
| Avg. Volume | 138,228 |
| Market Cap | 977,819 |
| Beta (5Y Monthly) | -0.65 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.0600 |
| Earnings Date | Sept 29, 2022 |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
- CNW Group
Molecule Holdings Inc. Provides Bi-Weekly MCTO Status Update
Molecule Holdings Inc. (CSE: MLCL) ("Molecule" or the "Company"), a Canadian craft-focused cannabis beverage production company, is providing a default status report in accordance with the alternative information guidelines set out in National Policy 12-203 – Management Cease Trade Orders ("NP 12-203").
- CNW Group
Molecule Holdings Inc. Clarifies Reason for Delay of Annual Filings
Molecule Holdings Inc. (CSE: MLCL) ("Molecule" or the "Company"), a Canadian craft-focused cannabis beverage production company, today announces that, further to its press release of February 10, 2023, the reason it anticipates the filing of its annual financial statements (the "2022 Annual Financial Statements"), management's discussion and analysis and related officer certifications for the financial year ended October 31, 2022 (collectively, the "Annual Filings") will be delayed beyond the re
- CNW Group
Molecule Holdings Inc. Announces Delay of Annual Filings
Molecule Holdings Inc. (CSE: MLCL) ("Molecule" or the "Company"), a Canadian craft-focused cannabis beverage production company, today announces that it anticipates the filing of its annual financial statements, management's discussion and analysis and related officer certifications for the financial year ended October 31, 2022 (collectively, the "Annual Filings") will be delayed beyond the required filing deadline under Parts 4 and 5 of National Instrument 51-102 – Continuous Disclosure Obligat
